Primary-Refractory acute myeloid leukemia (AML) is a form of leukemia that doesn’t respond to initial treatment, making continued progress in care options especially important. Michael Bern, MD, PhD is working to understand why this happens and how future therapies could offer more effective paths forward. ❤️ It’s one of the many ways we’re committed to AML research 👉 bit.ly/4pvvahW

The @US_FDA has approved a new treatment for high-risk smoldering multiple myeloma, a breakthrough that’s reshaping early-stage care. ❤️ More on what this means for patients 👉 bit.ly/3XjkF5q

The Dare to Dream Summit may be over, but the impact is just beginning. ❤️ Over 250 attendees united together to share ideas, drive progress, and push for more support for young people with blood cancer. A huge thank you to the incredible teams who brought it all to life - both on stage and behind the scenes. The work continues, and so does our commitment to this community. 🫶🌟🫂 @bcutd_advocacy

For those living with acute myeloid leukemia (AML), more options mean more hope. ❤️ The @US_FDA has expanded approval of a targeted therapy for AML, offering new treatment possibilities for more patients. Blood Cancer United supports research to better understand AML and identify new treatment approaches through scientific grants, clinical trials like Beat AML and Pediatric Acute Leukemia (PedAL), and our Therapy Acceleration Program®. Learn more about our ongoing commitment to AML research 👉 bit.ly/497sphS

Behind every research breakthrough are the people who want more birthdays, milestones, and everyday moments with the ones they love. ❤️ Together with the @HCLFoundation, we’re investing up to $7 million in the HCL2030 program to push research forward and create better options for patients with hairy cell leukemia. This continued collaboration will open up new therapeutic options for individuals with hairy cell leukemia (HCL). We proudly supported earlier work by Dr. Tiacci leading to a new treatment for people with relapsed HCL. On World Cancer Research Day, we honor patients at the heart of this mission, and the researchers who are making progress possible 👉 bit.ly/4gFD98L

#ICYMI: Blood Cancer United lit up the @Nasdaq billboard in Times Square yesterday! 🎉 Our co-workers pulled up to celebrate this iconic moment—united we’re unstoppable. 🫶

We do the most for people with blood cancer. So people with blood cancer, can do more of whatever they want. 🫶 The Leukemia & Lymphoma Society is now Blood Cancer United. ✨📢🎉 Learn more 👉 bit.ly/41XsvUO

What’s changed? 📣 Our name! We’re now the research team of @bloodcancerutd. What hasn’t? Our drive to fund bold research, fuel discoveries, and make life’s little moments possible—morning pancakes, movie nights, first-day-of-school walks. 🩸🔬

Zoom in! 🔎 Can you find the first comment in @LLSusa's post? 🤫 You’ll want to be here tomorrow 👀

Have you received CAR T-cells and wondered about possible effects on your fertility? Help us gather critical information to determine if CAR T-cells affect fertility: Who can participate? ✅ Adults over the age of 18 ✅ Received CAR T-cell therapy as a result of a blood cancer diagnosis Questions? ✉️ Email: pact@LLS.org 📞 Call: 914-821-8408 Take the survey today 👉 bit.ly/4lpqbwZ #CART

Basic blood cancer research funding opportunity! 🩸🔬 @LLSusa is now accepting LOIs for the Discovery Grant Program (DGP). Looking for foundational research projects to shed a new light on any or all of the blood cancers. Follow the link more and apply: 👉bit.ly/4laoDYe

Are you an early or mid-career blood cancer scientist/clinician? Our CDP grant program may just be the right fit for you! Visit our website for guidelines, deadlines and eligibility👉bit.ly/443iwgY Please repost and share! 🩸🔬

Look at him go! What can't @StefBPhD do? He is a rising 🌟of a leukemia scientist and a CDP Fellow, he runs marathons and raises funds for LLS 🩸 Read more about his project here: 👉 lls.org/award/metabolic-regu…

We're so excited about our new #LLSTAP partner @Solu_Tx! Our investment in the Series A helps us advance our mission to improve outcomes for all blood cancers—including rare, serious diseases like #CMML. Learn more 👉lls.org/tap

Thank you @LLSusa for funding our dietary research in newly diagnosed myeloma @MSKCancerCenter @MSK_DeptOfMed Enjoyed chatting with @DrGwenNichols @LLSusa for #MyelomaAwarenessMonth and #WomensHistoryMonth #mmsm Link here: bit.ly/4c5Zx90

Progress in action. ❤️ The @US_FDA has approved a new treatment combination for adults with large B-cell lymphoma, offering hope for those whose cancer has returned or worsened. Get the details 👉 bit.ly/41ulTxf

Some diffuse large B-cell lymphoma (DLBCL) patients—specifically African American patients and those with Epstein-Barr virus (EBV)—face worse outcomes. Backed by an LLS-funded grant, Dr. Jean Koff from @WinshipAtEmory is working to change that 👉 bit.ly/411z2N7

The recent cuts to lifesaving health research are one of many threats that people with cancer face. We stand with blood cancer patients. ❤️ Read more 👉 bit.ly/4gwjExS

Nearly 20 years ago, Drs. Grembecka & Cierpicki began pioneering research later supported by @LLSusa & Kura. Today, menin inhibitors that stemmed from their discoveries are being investigated in various genetic subsets of leukemia.​ Watch #FromLabToClinic: kuraoncology.com/perspective…

Dr. Stephen Oh from @WUSTL is diving into the causes of chronic myelomonocytic leukemia (CMML)—a rare blood disorder with limited treatment options. His research could lead to new therapies and brighter futures for patients. ❤️ Get the details 👉 bit.ly/4h3mkEj